ibandronic acid has been researched along with SAPHO Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eufémia Calmeiro, M; Gil, F; Gil, J; Mariano, P; Silva, S | 1 |
| Gangji, V; Margaux, J; Soyfoo, MS | 1 |
2 other study(ies) available for ibandronic acid and SAPHO Syndrome
| Article | Year |
|---|---|
SAPHO syndrome: the value of classic drugs in the era of biologics.
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Bone and Bones; Bone Density Conservation Agents; Cyclosporine; Drug Therapy, Combination; Female; Humans; Ibandronic Acid; Immunosuppressive Agents; Middle Aged; Prednisolone; Radionuclide Imaging | 2020 |
Successful treatment of SAPHO syndrome with ibandronate.
Topics: Acquired Hyperostosis Syndrome; Adult; Bone Density Conservation Agents; Diphosphonates; Dose-Response Relationship, Drug; Humans; Ibandronic Acid; Magnetic Resonance Imaging; Male; Treatment Outcome | 2010 |